Advanced glycation end-products: pathway of potentially significant pathophysiological and therapeutic relevance for metabolic syndrome in menopausal women.
Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, University of Vermont College of Medicine, Burlington, Vermont 05401.
Zaher
Z
Merhi
D000818:Animals; D002784:Cholesterol / Q000097:blood; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008074:Lipoproteins / Q000097:blood; D008593:Menopause / Q000378:metabolism*; D024821:Metabolic Syndrome / Q000209:etiology / Q000378:metabolism* / Q000628:therapy*; D051379:Mice; D012307:Risk Factors; D015398:Signal Transduction / Q000502:physiology; D014280:Triglycerides / Q000097:blood; D055105:Waist Circumference / Q000502:physiology
D017127:Glycation End Products, Advanced; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D014280:Triglycerides; C030104:lipoprotein cholesterol; D002784:Cholesterol